Lacosamide NDC 82804-993

Product information

Brand name (proprietary)

Lacosamide

Generic name (nonproprietary)

lacosamide

Active ingredients

Lacosamide — 200 mg/1

Dosage form

Tablet, Film coated

Route

Oral

Labeler

Proficient Rx LP

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 205237

Marketing start

Jul 10, 2023

Listing expires

Dec 31, 2026

DEA schedule

CV

Other FDA classes

Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)

Identifiers

Product ID 82804-993_47ae2f1f-d135-4f4e-acc2-500c1afa7b8bSPL ID 47ae2f1f-d135-4f4e-acc2-500c1afa7b8bSPL set ID 47ae2f1f-d135-4f4e-acc2-500c1afa7b8bRxCUI 809987, 809992, 809996, 810000UNII 563KS2PQY5UPC 0382804993307, 0382804991303, 0382804990306, 0382804992300

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N482804099300 followed by a unit qualifier and the quantity Copy

Package 82804-0993-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 205237

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.